GlaxoSmithKline PLC (NYSE:GSK) closed its last session at $43.15 with the change of +1.51%. The market capitalization of the company is $104.88B with an average Volume of 3.29 million shares. The stock currently has its 52-Week High range of $45.58 and 52-week low range of $37.24. The Price to Book (P/B) ratio stands at 137.13. The stock traded total quantity of 2.72 million shares.
Currently GlaxoSmithKline PLC (GSK) captured an average recommendation of “ Hold ” from analysts, according to FactSet data. The stock has been suggested as “Buy” from “9″ Analysts”. “3” rated “Sell” for the company. “13” said the company as a “Hold”. Overweight rating was given by “1” and Underweight rating was given by “0”.
Analysts are expecting that the company to achieve $46.97 Price Target in next 52-weeks, average price is come up through the consensus of analysts. High potential price target is set at $53.61 however minimum price target advised by analysts is $35.10. The Median price target for the stock is measured at $47.90.
Presently, Analysts decided consensus EPS estimate of $0.77 for present quarter and one month ago projected EPS estimate was at $0.76. If we take a look at back 3 month ago, consensus EPS estimate was $0.76.
A current consensus EPS estimate for next quarter is at $0.62 and 3 month ago EPS forecast was $0.65. Have a look at back 1 month ago, consensus EPS forecast was seen at $0.62.
For current fiscal year, most recent EPS estimate is set at $2.54 based on Analyst consensus and three month ago consensus EPS opinions was at $2.54. During period one month ago, consensus EPS forecast was decided at $2.54.
A current consensus EPS projection for next fiscal year is observed at $2.72 and one month ago consensus EPS forecast was at $2.71. Take a look at back three month ago, consensus EPS estimate opinions was decided at $2.66 by analysts.
One Month ago, the stock has gained consensus mean rating of Hold based on the analysis of brokerage analyst firms polled. 8 presented the recommendations about the stock as a “Buy” signal and “Overweight” signal was reported by 1. 15 advised the “Hold” rating about this stock. 2 revealed “Sell” signal and “Underweight” rating was declared by 0.
Three Months Ago, Analysts recommended an average brokerage rating of Hold derived from brokerage firms, according to FactSet. 7 said a “Buy Rating” and 0 announced “Overweight Rating”. 18 advised “Hold Rating” regarding the stock. 2 announced “Sell Rating” and 0 disclosed “Underweight Rating”.